Project Grant HT9425261E135
Award Date 9/1/26
Completion Date 8/31/30
Dollars Obligated $3.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
North Chicago, IL 60064, USA
Similar Awards
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded UC San Diego a $3.495 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the four-year period from July 1, 2026, through June 30, 2030. The project focuses on the development of disease-modifying therapies for fibrous dysplasia using a targeted protein degradation approach. This award supports basic and applied biomedical research aligned with DHA's mission to advance innovative...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the University of California, Los Angeles a $1.70 million Project Grant on June 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "The 3D Multiomic Determinants of Prostate Cancer Lethality." The three-year project, with completion targeted for May 31, 2029, will be performed at UCLA's Los Angeles campus and is expected to deliver investigator-initiated biomedical...
- Federal Grant Award Summary The University of Chicago received a $869,193 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025 through June 30, 2028. The award funds research to identify the pathogenesis of monosomy 7 in bone marrow failure (BMF), a basic biomedical research initiative aligned with the program's objective to transform healthcare for service members and the American public through...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded UCLA a $799,999 Project Grant effective May 1, 2026, through April 30, 2030, under the Military Medical Research and Development program (CFDA 12.420). The project, titled "From H & E to HRD: Linking Morphometry, Clinical, and Molecular Data for Drug Response Prediction," supports biomedical research designed to advance medical solutions for Service Members and the military population. This award represents...
- This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the Regents of the University of Michigan a $1.7 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 through June 30, 2029. The project, titled "Targeted Disruption of the ARP300 Enhanceosome in Prostate Cancer Using Domain-Alteration Chimeras (DALTACs)," focuses on developing a novel therapeutic approach to combat prostate cancer through the use...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the University of Wisconsin–Madison a $1,074,650 project grant under the Military Medical Research and Development program (CFDA 12.420) on September 1, 2025, with an ultimate completion date of August 31, 2029. The grant supports investigation of the immunomodulatory effects of chemokine signaling in renal cell carcinoma, representing a hypothesis-driven biomedical research initiative designed to advance innovative...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $1.1 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, through May 31, 2030. The project, titled "Uncovering Targetable Vulnerabilities in Leukemic Stem Cells," represents basic and applied biomedical research aimed at advancing medical solutions relevant to Service Member health and the...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $993,283 Project Grant to The Regents of the University of California, San Francisco under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2027. The award supports research into the proteomic determinants and components of progression in multiple sclerosis. This research initiative aligns with the DHA's mission to transform healthcare for service members...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Loyola University of Chicago Health Sciences Campus a $1.696 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) on September 1, 2026, with a three-year performance period extending through August 31, 2029. This award funds research investigating the use of novel angiopoietin-1 mimetic peptides for treating burn shock-associated endothelial dysfunction in severe burn injury....